BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18565128)

  • 1. TLR2/6 stimulation of the rat lung: effects on lymphocyte subsets, natural killer cells and dendritic cells in different parts of the air-conducting compartments and at different ages.
    Pabst R; Durak D; Roos A; Lührmann A; Tschernig T
    Immunology; 2009 Jan; 126(1):132-9. PubMed ID: 18565128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local pulmonary immune stimulation by the Toll-like receptor 2 and 6 ligand MALP-2 in rats is age dependent.
    Lührmann A; Grote K; Stephan M; Tschernig T; Pabst R
    Immunol Lett; 2007 Feb; 108(2):167-73. PubMed ID: 17275100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of mycoplasma lipoprotein MALP-2 to induce NK cell activation through dendritic cell TLR2.
    Sawahata R; Shime H; Yamazaki S; Inoue N; Akazawa T; Fujimoto Y; Fukase K; Matsumoto M; Seya T
    Microbes Infect; 2011 Apr; 13(4):350-8. PubMed ID: 21172450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of TLR-2/6 ligation in pulmonary bacterial infection and immunization with Pseudomonas aeruginosa.
    Kerber-Momot T; Leemhuis D; Lührmann A; Munder A; Tümmler B; Pabst R; Tschernig T
    Inflammation; 2010 Feb; 33(1):58-64. PubMed ID: 19844782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TLR-2/TLR-6 agonist macrophage-activating lipopeptide-2 augments human NK cell cytotoxicity when PGE2 production by monocytes is inhibited by a COX-2 blocker.
    Müller C; Tufa DM; Chatterjee D; Mühlradt PF; Schmidt RE; Jacobs R
    Cancer Immunol Immunother; 2015 Sep; 64(9):1175-84. PubMed ID: 26036909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of lymphocyte subsets, monocytes, and NK cells in three different lung compartments and peripheral blood in the rat.
    Fliegert FG; Tschernig T; Pabst R
    Exp Lung Res; 1996; 22(6):677-90. PubMed ID: 8979050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of pulmonary immune responses by the TLR2/6 agonist MALP-2 and effect on melanoma metastasis to the lung.
    Schill T; Schön MP; Pletz N; Emmert S; Schön M
    Exp Dermatol; 2012 Feb; 21(2):91-8. PubMed ID: 22044500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte subsets in distinct lung compartments show a different ability to produce interferon-gamma (IFN-gamma) during a pulmonary immune response.
    Klemm A; Tschernig T; Krug N; Pabst R
    Clin Exp Immunol; 1998 Aug; 113(2):252-7. PubMed ID: 9717975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial.
    Schmidt J; Welsch T; Jäger D; Mühlradt PF; Büchler MW; Märten A
    Br J Cancer; 2007 Sep; 97(5):598-604. PubMed ID: 17667928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The peptide sequence of diacyl lipopeptides determines dendritic cell TLR2-mediated NK activation.
    Azuma M; Sawahata R; Akao Y; Ebihara T; Yamazaki S; Matsumoto M; Hashimoto M; Fukase K; Fujimoto Y; Seya T
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recruitment of lymphocytes and dendritic cells from the blood to the bronchoalveolar space and the draining lymph nodes after a single intrabronchial application of the lipopeptide MALP-2.
    Tschernig T; Lührmann A; Pabst R
    Pathobiology; 2002-2003; 70(5):260-5. PubMed ID: 12771506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct stimulatory effects of the TLR2/6 ligand bacterial lipopeptide MALP-2 on neutrophil granulocytes.
    Wilde I; Lotz S; Engelmann D; Starke A; van Zandbergen G; Solbach W; Laskay T
    Med Microbiol Immunol; 2007 Jun; 196(2):61-71. PubMed ID: 17006695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage-activating lipopeptide-2 (MALP-2) induces a localized inflammatory response in rats resulting in activation of brain sites implicated in fever.
    Knorr C; Hübschle T; Murgott J; Mühlradt P; Gerstberger R; Roth J
    Brain Res; 2008 Apr; 1205():36-46. PubMed ID: 18353287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor-2/6 and Toll-like receptor-9 agonists suppress viral replication but not airway hyperreactivity in guinea pigs.
    Drake MG; Evans SE; Dickey BF; Fryer AD; Jacoby DB
    Am J Respir Cell Mol Biol; 2013 Jun; 48(6):790-6. PubMed ID: 23449736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Toll-like receptor 2/6 agonist reduces allergic airway inflammation in chronic respiratory sensitisation to Timothy grass pollen antigens.
    Fuchs B; Knothe S; Rochlitzer S; Nassimi M; Greweling M; Lauenstein HD; Nassenstein C; Müller M; Ebensen T; Dittrich AM; Krug N; Guzman CA; Braun A
    Int Arch Allergy Immunol; 2010; 152(2):131-9. PubMed ID: 20016195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 2/6 agonist macrophage-activating lipopeptide-2 promotes reendothelialization and inhibits neointima formation after vascular injury.
    Grote K; Sonnenschein K; Kapopara PR; Hillmer A; Grothusen C; Salguero G; Kotlarz D; Schuett H; Bavendiek U; Schieffer B
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2097-104. PubMed ID: 23868938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porin differentiates TLR mediated proinflammatory response of follicular zone B cell from TLR-unresponsive IL-10 expressing marginal zone B cell.
    Sinha D; Ghosh AK; Mukherjee S; Biswas R; Biswas T
    Cytokine; 2015 Dec; 76(2):193-205. PubMed ID: 26174952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptide.
    Shen KY; Song YC; Chen IH; Chong P; Liu SJ
    Hum Vaccin Immunother; 2014; 10(11):3241-50. PubMed ID: 25483652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells.
    Borsutzky S; Kretschmer K; Becker PD; Mühlradt PF; Kirschning CJ; Weiss S; Guzmán CA
    J Immunol; 2005 May; 174(10):6308-13. PubMed ID: 15879130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotypical characterization in Andalusian horse: variations with age and gender.
    Satué K; Hernández A; Lorente C; O'Connor JE
    Vet Immunol Immunopathol; 2010 Feb; 133(2-4):219-27. PubMed ID: 19735948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.